Nemesis

What Nemesis does

Nemesis Co., Ltd. (네메시스) is a South Korean privately-held semiconductor design company founded on October 17, 2017, and headquartered at the Pangyo Digital Center in Seongnam-si, Gyeonggi-do. The company specializes in CMOS-based intelligent bio-signal processing SoC design for bio/medical device manufacturers and digital healthcare OEMs. Its stated objective is to enable preemptive diagnostics by improving the signal-to-noise ratio of bio-signal acquisition in miniaturized, low-power form factors.

The company's core technology combines analog mixed-signal semiconductor design expertise with TinyML algorithm optimization at the silicon level. It markets a portfolio of four named IP/SoC products: the NMS4110 electrochemical sensor read-out IC (ROIC) for CGM, ECG, and bipotentiostat applications; the NMI1000 programmable capacitance-to-digital converter SoC for image sensing and capsule endoscopy; the NMS3150 silicon-proven force/torque sensing IP; and the NMS4150, its flagship SoC integrating a 32-bit RISC-V core with TinyML support, on-chip Flash/SRAM, and an integrated power manager. A registered patent covers its Intelligent Bio-signal Processing Technology. Target use cases span heart rate, ECG, blood pressure, virus biomarker diagnostics, and capsule endoscopy.

Nemesis operates a dual-pillar business model: (1) licensing of proprietary bio-signal processing semiconductor IP for royalty or one-time license revenue, and (2) consultative customization design services in which engineers engage directly with bio/medical device manufacturers from specification through delivery. The GTM motion is exclusively direct enterprise field sales, with no resellers or third-party distribution channels; pricing is quote-based and not publicly disclosed. As of latest disclosure, the company has raised approximately 4 billion KRW (~$3M USD) across four institutional rounds (2018, 2020, 2021, 2023), with its 2021 round led by Capstone Partners, K Ground Ventures, and UTC Investment Co. It has been recognized through Korean government programs including TIPS (2018), BIG3 (2022), and military service exception research lab status (2022).

Name

Nemesis

Legal name

네메시스 주식회사 (Nemesis Co., Ltd.)

Website

https://nemesis.kr

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Short description

Nemesis is a South Korean semiconductor design company that develops CMOS-based intelligent bio-signal processing SoCs and analog IP for bio/medical device manufacturers, combining proprietary TinyML optimization with consultative customization services across electrochemical sensing, CDC, and force/torque applications.

Ownership category

akta.pro rank

Product category

Medical Device Semiconductors (Bio-signal Processing SoC IP)

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Instrument Manufacturing for Measuring and Testing Electricity and Electrical Signals (334515)

SIC

Semiconductors & Related Devices (3674)

akta.pro primary industry

Hardware/Chip Design IP Cores (Processor, Interface, Analog, Security) (HDAHAFAF)

akta.pro secondary industry

Verification IP (VIP) & Protocol Compliance Suites (HDAHAFAG)

Keywords

• Bio-signal processing SoC
• Medical device semiconductors
• TinyML algorithm optimization
• Electrochemical sensor read-out
• Custom semiconductor design

Headquarters

HQ city

Seongnam

HQ country

South Korea

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Custom Semiconductor Design Services: Consultative customization services providing customer-specific semiconductor solutions. The process involves defining customer requirements, validating specifications, and delivering tailored SoC solutions for bio-signal processing applications.
2. Semiconductor IP Licensing: Licensing of proprietary bio-marker and vital sign signal processing IP including NMS4110, NMI1000, NMS3150, and NMS4150 products to bio/medical device manufacturers.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Nemesis designs and licenses CMOS-based intelligent bio-signal processing semiconductor intellectual property (IP) and System-on-Chip (SoC) solutions for bio/medical device manufacturers. Its portfolio includes the NMS4110 electrochemical sensor ROIC, NMI1000 programmable CDC SoC, NMS3150 force/torque sensing IP, and NMS4150 flagship bio-signal processing SoC with RISC-V core and TinyML support. In parallel, it offers consultative custom semiconductor design services that transform customer specifications into tailored bio-diagnostic SoC solutions.

Product overview

Nemesis is a semiconductor design company specializing in intelligent bio-signal processing solutions. The product portfolio consists of two main pillars: (1) Proprietary semiconductor IP and SoC products including the NMS4110 (Electrochemical Sensor ROIC), NMI1000 (Programmable CDC SoC), NMS3150 (Force/Torque Sensing), and NMS4150 (flagship Intelligent Bio-signal Processing SoC with RISC-V core and TinyML support); and (2) Consultative Customizing Services for customer-specific semiconductor development. All products are designed around the core principles of Small size, Low Power, and Accurate diagnostics for healthcare and medical device applications.

Differentiator

Problem solved

Functional benefit

Products and services

• NMS4110 Electrochemical Sensor ROIC Electrochemical Sensor Read-Out Integrated Circuit (ROIC) IP targeting Continuous Glucose Monitoring (CGM), Electrocardiogram (ECG), and Bipotentiostat applications for bio/medical device manufacturers.
• NMI1000 Programmable CDC SoC Programmable Capacitance-to-Digital Converter System-on-Chip (CDC SoC) designed for image sensing and capsule endoscopy applications.
• NMS3150 Force/Torque Sensing IP Silicon-proven force and torque sensing IP for precision measurement applications.
• NMS4150 Intelligent Bio-signal Processing SoC Flagship Intelligent Bio-signal Processing SoC integrating a 32-bit RISC-V core, 64KB Flash, 32KB SRAM, Tiny Machine Learning support, I2C/SPI/UART interfaces, and an integrated power manager for low-power electrochemical sensor read-out applications.
• Consultative Customizing Services Custom semiconductor design and development services that transform bio/medical device customer ideas into tailored semiconductor solutions, covering specification definition, IP integration and verification, and long-term partnership-based customization.

Quantifiable outcome

• Improved signal-to-noise ratio for bio-signal processing enabling high-fidelity diagnostic accuracy

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature6 records

Scale indicators1 record

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Renesas Electronics: Renesas Electronics (which acquired Dialog Semiconductor and Intersil) provides low-power mixed-signal ICs, microcontrollers, and analog IP widely adopted in medical and bio-signal applications. It competes with Nemesis at the OEM chip level for medical biosensor devices but with much broader portfolio and customer footprint.
• ams-OSRAM: ams-OSRAM is a global sensor and analog mixed-signal IC supplier with a strong medical and health-sensing portfolio, including optical bio-sensor front-ends, ECG, and wearable health monitoring solutions. Comparable to Nemesis in target applications and mixed-signal design, but with vastly larger resources and global reach.
• Silicon Laboratories (Silicon Labs): Silicon Labs provides mixed-signal ICs, low-power MCUs, and wireless SoCs with a dedicated portfolio serving connected health, wearable, and medical device OEMs. Comparable to Nemesis in mixed-signal and low-power design DNA, but operates at much greater scale with broader market coverage.
• Nordic Semiconductor: Nordic Semiconductor is an established fabless supplier of ultra-low-power short-range wireless SoCs widely used in medical wearables, biosensors, and connected health devices. It competes with Nemesis in providing low-power mixed-signal platforms for medical OEMs but at significantly larger scale and broader portfolio.
• Texas Instruments: Texas Instruments supplies a broad portfolio of analog front-end, low-power MCU, and precision signal-chain ICs used in medical bio-signal acquisition (CGM, ECG, patient monitoring). Comparable in end-market and analog expertise to Nemesis, but operates at industrial scale with much wider IP coverage.
• STMicroelectronics: STMicroelectronics produces low-power MCUs, MEMS sensors, and analog front-end ICs for medical wearables, continuous monitoring, and bio-signal applications. Comparable to Nemesis in bio-signal and low-power SoC positioning, but at much larger scale and broader portfolio.
• Analog Devices (formerly Maxim Integrated): Analog Devices (including the former Maxim Integrated portfolio) is a leading analog/mixed-signal IC supplier with deep penetration in medical devices, bio-signal acquisition, low-power analog front-ends, and CGM/ECG signal chains. It addresses the same applications as Nemesis (CGM, ECG, Bipotentiostat) but with vastly greater resources and incumbency.

Direct peers

• Ambiq Micro: Ambiq Micro designs ultra-low-power SoCs using subthreshold power optimization technology for wearables, hearables, and IoT medical devices — a comparable positioning to Nemesis' 'Small, Low Power, Accurate' bio-signal SoC value proposition. Both compete in enabling always-on, miniaturized health-monitoring endpoints.
• Syntiant: Syntiant designs ultra-low-power neural decision processors (SoCs) for always-on edge AI inference in sensor-based applications, directly comparable to Nemesis' low-power TinyML bio-signal SoCs. Both target the convergence of low-power analog/mixed-signal design with on-device machine learning for compact, battery-constrained devices.
• PixArt Imaging: PixArt Imaging is an Asian fabless semiconductor company specializing in low-power image sensors, capacitive sensing SoCs, and related mixed-signal ICs — directly comparable to Nemesis' NMI1000 programmable CDC SoC for image sensing and capsule endoscopy. Both serve compact, low-power medical and IoT sensing applications.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/nemesis-co-ltd

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds3 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nemesis